VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...
Clinical trial NCT00858611 · COMPLETED
Trial details
- NCT number
- NCT00858611
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-03
- Primary completion
- 2010-06-21
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.